The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.

CONCLUSION: In summary, P2X7R is expected to become a potential target for the treatment of lung cancer, and more clinical research is needed in the future to explore the effectiveness of P2X7R antagonists as treatments.
PMID: 32892231 [PubMed - indexed for MEDLINE]

Source: Clinical Lung Cancer - October 8, 2020 Category: Cancer & Oncology Authors: Li Q, Zhu X, Song W, Peng X, Zhao R Tags: J Cancer Res Clin Oncol Source Type: research